Immune Modulator

Thymosin Alpha-1
Immune system optimization peptide

Starting at $295

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid peptide produced by the thymus gland that regulates and enhances immune function. It activates T-cells, dendritic cells, and NK cells — used clinically in oncology, infectious disease, and as part of longevity protocols for immune optimization in aging patients.

Licensed Metabolic MDsSubcutaneous injectionResults in 2–4 weeks
Thymosin Alpha-1 peptide therapy

Thymic immune restoration.

1

Adaptive Immunity

T-Cell Activation

Increases T-helper cell (CD4+) and cytotoxic T-cell (CD8+) activity, restoring cellular immune surveillance that declines with age and immune suppression.

Result: Restored T-cell function and adaptive immune capacity

2

Innate Immunity

Dendritic Cell Maturation

Promotes maturation of dendritic cells — the sentinels that detect pathogens and coordinate immune responses. Improves the quality of both innate and adaptive immune responses.

Result: Enhanced pathogen detection and coordinated immune response

3

Cancer Surveillance

NK Cell Enhancement

Increases natural killer (NK) cell activity — the immune system's primary defense against cancer cells and viral infections. NK cell decline with age is a major driver of increased cancer risk.

Result: Enhanced immune surveillance against cancer cells and viruses

Clinical Benefits

What you can expect from Thymosin Alpha-1 therapy

Immune system restoration

Restores T-cell function and adaptive immunity that declines with age, illness, or immune suppression.

Infection protection

Enhanced NK cell and T-cell activity improves resistance to viral infections, including chronic viral conditions.

Cancer immune surveillance

NK cell activation increases detection and elimination of cancer cells — particularly valuable in longevity protocols.

Anti-inflammatory regulation

Modulates inflammatory cytokines, reducing chronic low-grade inflammation associated with aging and metabolic disease.

Vaccine response

Clinical data shows Tα1 improves vaccine efficacy in immunocompromised patients and the elderly.

Approved globally

Approved in 35+ countries for hepatitis B, hepatitis C, and as an adjunct to cancer treatment.

The Process

What to expect & when

Realistic timeline for Thymosin Alpha-1 results

1

Weeks 1–2

T-Cell Activation

T-cell and NK cell counts begin rising. Some patients notice improved energy and reduced frequency of minor illnesses.

2

Weeks 2–6

Immune Restoration

Adaptive immune function progressively restored. Inflammatory markers begin normalizing.

3

2–6 Months

Comprehensive Immune Optimization

Full immune system restoration including T-helper/cytotoxic cell balance, NK cell activity, and dendritic cell function.

4

Maintenance

Sustained Immune Health

Periodic use maintains immune optimization, particularly in aging patients or those with chronic immune challenges.

Common questions

Everything you need to know about Thymosin Alpha-1 therapy

Transparent Pricing

Consultation Fees

Physician-guided care with complete pricing clarity.

Generic Consultation

Includes Any & All Services

First Visit

$400

Follow-Up

$150

  • Complete health assessment
  • All service areas covered
  • Personalized treatment plan
  • Prescription if appropriate
Get Started

Specialized Consultation

Skin, Hair, Wellness, Labs, Galleri

First Visit

$300

Follow-Up

$150

  • Focused specialty review
  • Lab analysis included
  • Targeted treatment approach
  • Follow-up protocol
Get Started

Peptide Consultation

Weight loss & metabolic therapies

First Visit

$50

Follow-Up

$30

  • Metabolic assessment
  • GLP-1 or peptide evaluation
  • Dosing strategy
  • Prescription included
Get Started